HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis
about
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infectionCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersEnhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay.Optimizing Human Immunodeficiency Virus Testing Interventions for Men Who Have Sex With Men in the United States: A Modeling Study.Ten Years of Screening and Testing for Acute HIV Infection in North CarolinaIncorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi.Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.Improving the Quality of Diagnostic Studies Evaluating Point of Care Tests for Acute HIV Infections: Problems and RecommendationsComparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia.Real-life evaluation of a human immunodeficiency virus screening algorithm using a single combined p24 antigen-antibody assay.Evaluating the Evidence for More Frequent Than Annual HIV Screening of Gay, Bisexual, and Other Men Who Have Sex With Men in the United States: Results From a Systematic Review and CDC Expert Consultation.p24 revisited: a landscape review of antigen detection for early HIV diagnosis
P2860
Q24607025-ACC81B56-6CF2-44B4-8A54-8A4FC896B2F6Q28483820-E97292C5-7809-4314-BDDC-6EF4C680AB79Q35542113-EB17755A-12CA-4247-8EF6-C0998C47D855Q36302031-169B978D-1603-4124-A563-A17CB55C3DD1Q36462152-9EF64F4E-F00B-4D0A-AFD9-D732518ADD07Q36576458-DCD89FC6-8606-440D-9F21-8C03587C66F4Q36628388-B358EDAF-D0BA-4702-B42C-D659D935A2EAQ37643303-BFE47175-EA91-47E0-B767-D0A9AFFE6D41Q37729977-3AAF67CD-5C5A-4AC5-8146-41F47D71BF53Q41280296-688D7267-ED16-4D8B-A34C-CAD997AC285FQ42925387-86CDA154-2FDC-4176-BDF8-F939C4719FC6Q44393252-E1DC2A06-0DA7-4E19-B4EB-A9D68AF66DDCQ47572010-6E96200F-3497-48A9-9BC8-C21BDAF01F42Q57150995-C046CEEF-21E6-4DA3-A9EF-235D49095CD1
P2860
HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@ast
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@en
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@nl
type
label
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@ast
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@en
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@nl
prefLabel
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@ast
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@en
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@nl
P2860
P1433
P1476
HIV screening via fourth-gener ...... a cost-effectiveness analysis
@en
P2093
Elisa F Long
P2860
P304
P356
10.1371/JOURNAL.PONE.0027625
P407
P577
2011-01-01T00:00:00Z